Noe Rodriguez-Rodriguez

Noe Rodriguez-Rodriguez

Auto-generated profile, based on publicly available information

Noe Rodriguez-Rodriguez

MRC Laboratory of Molecular Biology, Cambridge, United Kingdom

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2016 in Nature Immunology
Verified
Journal Article
Open access
PDF file
SASokratis A Apostolidis
Sokratis A Apostolidis
NRNoé Rodríguez-Rodríguez
Noé Rodríguez-Rodríguez
AFAbel Suarez Fueyo
Abel Suarez Fueyo
NDNikolina Dioufa
Nikolina Dioufa
EOEsra Ozcan
Esra Ozcan
GTGeorge Tsokos
George Tsokos
Regulatory T cells use a distinct metabolism to exert their regulatory function. Tsokos and colleagues show that the phosphatase PP2A suppresses the metabolic-checkpoint kinase complex mTORC1 in these cells and is necessary for their function. PP2A activity is regulated by the cellular abundance of ceramide via a transcription factor Foxp3–dependent feedback mechanism. Homeostasis of the immune system depends on the proper function of regulatory T cells (Treg cells). Compromised suppressive activity of Treg cells leads to autoimmune disease and graft rejection and promotes anti-tumor immunity. Here we report a previously unrecognized requirement for the serine-threonine phosphatase PP2A in the function of Treg cells. Treg cells exhibited high PP2A activity, and Treg cell–specific ablation of the PP2A complex resulted in a severe, multi-organ, lymphoproliferative autoimmune disorder. Mass spectrometry revealed that PP2A associated with components of the mTOR metabolic-checkpoint kinase pathway and suppressed the activity of the mTORC1 complex. In the absence of PP2A, Treg cells altered their metabolic and cytokine profile and were unable to suppress effector immune responses. Therefore, PP2A is required for the function of Treg cells and the prevention of autoimmunity.

3 September 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
Christian HedrichChristian Hedrich
Christian Hedrich
TRThomas Rauen
Thomas Rauen
SASokratis A. Apostolidis
Sokratis A. Apostolidis
AGAlexandros P. Grammatikos
Alexandros P. Grammatikos
NRNoe Rodriguez Rodriguez
Noe Rodriguez Rodriguez
GTGeorge Tsokos
George Tsokos
Significance: IL-10 is an immune-regulatory cytokine with pro- and anti-inflammatory functions. Through its B cell-stimulating capacities, IL-10 contributes to the differentiation, activation and survival of B cells. Thus, it has been linked with autoimmune disorders, including systemic lupus erythematosus (SLE). Here, we demonstrate T cells as a source of increased IL-10 expression in SLE. Reduced DNA methylation of the IL10 gene allows for transcription-factor recruitment. Increased phosphorylation of the transcription factor Stat3 in SLE T cells results in epigenetic remodeling and trans -activation of IL10 , allowing for IL-10 expression. Thus, our observations offer molecular targets in the search for pathophysiologic mechanisms and target-directed treatment options in SLE.

1 July 2019 in Immunity
Verified
Journal Article
Open access
JWJennifer A. Walker
Jennifer A. Walker
PCPaula A. Clark
Paula A. Clark
ACAlastair Crisp
Alastair Crisp
JBJillian L. Barlow
Jillian L. Barlow
ASAydan Szeto
Aydan Szeto
AMAndrew N.J. McKenzie
Andrew N.J. McKenzie
Innate lymphoid cells (ILCs) play strategic roles in tissue homeostasis and immunity. ILCs arise from lymphoid progenitors undergoing lineage restriction and the development of specialized ILC subsets. We generated "5x polychromILC" transcription factor reporter mice to delineate ILC precursor states by revealing the multifaceted expression of key ILC-associated transcription factors (Id2, Bcl11b, Gata3, RORγt, and RORα) during ILC development in the bone marrow. This approach allowed previously unattained enrichment of rare progenitor subsets and revealed hitherto unappreciated ILC precursor heterogeneity. In vivo and in vitro assays identified precursors with potential to generate all ILC subsets and natural killer (NK) cells, and also permitted discrimination of elusive ILC3 bone marrow antecedents. Single-cell gene expression analysis identified a discrete ILC2-committed population and delineated transition states between early progenitors and a highly heterogeneous ILC1, ILC3, and NK precursor cell cluster. This diversity might facilitate greater lineage potential upon progenitor recruitment to peripheral tissues.

27 June 2019 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
BRBatika M.J. Rana
Batika M.J. Rana
EJEric Jou
Eric Jou
JBJillian L. Barlow
Jillian L. Barlow
NRNoe Rodriguez-Rodriguez
Noe Rodriguez-Rodriguez
JWJennifer A. Walker
Jennifer A. Walker
AMAndrew N.J. McKenzie
Andrew N.J. McKenzie
Group-2 innate lymphoid cells (ILC2), type-2 cytokines, and eosinophils have all been implicated in sustaining adipose tissue homeostasis. However, the interplay between the stroma and adipose-resident immune cells is less well understood. We identify that white adipose tissue–resident multipotent stromal cells (WAT-MSCs) can act as a reservoir for IL-33, especially after cell stress, but also provide additional signals for sustaining ILC2. Indeed, we demonstrate that WAT-MSCs also support ICAM-1–mediated proliferation and activation of LFA-1–expressing ILC2s. Consequently, ILC2-derived IL-4 and IL-13 feed back to induce eotaxin secretion from WAT-MSCs, supporting eosinophil recruitment. Thus, MSCs provide a niche for multifaceted dialogue with ILC2 to sustain a type-2 immune environment in WAT.

3 June 2022 in Science Immunology
Verified
Journal Article
Open access
EJEric Jou
Eric Jou
NRNoe Rodriguez-Rodriguez
Noe Rodriguez-Rodriguez
AFAna-Carolina F. Ferreira
Ana-Carolina F. Ferreira
HJHelen E. Jolin
Helen E. Jolin
PCPaula A. Clark
Paula A. Clark
AMAndrew N. J. McKenzie
Andrew N. J. McKenzie
Interleukin-25 (IL-25) and group 2 innate lymphoid cells (ILC2s) defend the host against intestinal helminth infection and are associated with inappropriate allergic reactions. IL-33–activated ILC2s were previously found to augment protective tissue-specific pancreatic cancer immunity. Here, we showed that intestinal IL-25–activated ILC2s created an innate cancer-permissive microenvironment. Colorectal cancer (CRC) patients with higher tumor IL25 expression had reduced survival and increased IL-25R–expressing tumor-resident ILC2s and myeloid-derived suppressor cells (MDSCs) associated with impaired antitumor responses. Ablation of IL-25 signaling reduced tumors, virtually doubling life expectancy in an Apc mutation–driven model of spontaneous intestinal tumorigenesis. Mechanistically, IL-25 promoted intratumoral ILC2s, which sustained tumor-infiltrating MDSCs to suppress antitumor immunity. Therapeutic antibody-mediated blockade of IL-25 signaling decreased intratumoral ILC2s, MDSCs, and adenoma/adenocarcinoma while increasing antitumor adaptive T cell and interferon-γ (IFN-γ)–mediated immunity. Thus, the roles of innate epithelium-derived cytokines IL-25 and IL-33 as well as ILC2s in cancer cannot be generalized. The protumoral nature of the IL-25–ILC2 axis in CRC highlights this pathway as a potential therapeutic target against CRC.

1 January 2014 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
Christian HedrichChristian Hedrich
Christian Hedrich
JCJosé C. Crispín
José C. Crispín
TRThomas Rauen
Thomas Rauen
CIChristina Ioannidis
Christina Ioannidis
TKTomohiro Koga
Tomohiro Koga
GTGeorge Tsokos
George Tsokos
TCR-αβ+CD3+CD4−CD8− “double negative” T cells are expanded in the peripheral blood of patients with systemic lupus erythematosus (SLE) and lupus-prone mice. Double negative T cells have been claimed to derive from CD8+ cells that down-regulate CD8 co-receptors and acquire a distinct effector phenotype that includes the expression of proinflammatory cytokines. This, along with the fact that double negative T cells have been documented in inflamed organs, suggests that they may contribute to disease expression and tissue damage. We recently linked the transcription factor cAMP responsive element modulator (CREM) α, which is expressed at increased levels in T cells from SLE patients and lupus prone MRL/lpr mice, with trans-repression of a region syntenic to the murine CD8b promoter. However, the exact molecular mechanisms that result in a stable silencing of both CD8A and CD8B genes remain elusive. Here, we demonstrate that CREMα orchestrates epigenetic remodeling of the CD8 cluster through the recruitment of DNA methyltransferase (DNMT) 3a and histone methyltransferase G9a. Thus, we propose that CREMα is essential for the expansion of double negative T cells in SLE. CREMα blockade may have therapeutic value in autoimmune disorders with DN T cell expansion.